Inventor · disambiguated record
Helmut Jonuleit
Also filed as: JONULEIT HELMUT
9 granted patents·3 pending applications·154 citations·filing 2004–2020
88Inventor score
Top patents by PatentIndex Score
12 records- 0197US7452981B2Humanized anti-CD4 antibody with immunosuppressive propertiesBIOTEST AG·Filed 2005·Granted Nov 18, 2008·90 cites·4 claims
- 0293US9758581B2Humanized anti-CD4 antibody with immunosuppressive propertiesBIOTEST AG·Filed 2014·Granted Sep 12, 2017·18 cites·15 claims
- 0392US8673304B2Humanized anti-CD4 antibody with immunosuppressive propertiesWIJDENES JOHN·Filed 2009·Granted Mar 18, 2014·21 cites·6 claims
- 0492US8440806B2Humanized anti-CD4 antibody with immunosuppressive propertiesWIJDENES JOHN·Filed 2009·Granted May 14, 2013·20 cites·11 claims
- 0578US8685651B2Method for screening for an anti-CD4 antibody suitable for use in immunotherapyWIJDENES JOHN·Filed 2009·Granted Apr 1, 2014·2 cites·3 claims
- 0678US8586715B2Humanized anti-CD4 antibody with immunosuppressive propertiesWIJDENES JOHN·Filed 2008·Granted Nov 19, 2013·2 cites·3 claims
- 0764US8557533B2Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4SCHNEIDER FRANZ-JOSEF·Filed 2008·Granted Oct 15, 2013·1 cites·35 claims
- 0863US2020316167A1Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4UNIV DER JOHANNES GUTENBERG UNIV MAINZ·Filed 2020·Application pending·0 cites
- 0952US10729742B2Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4TCF GMBH·Filed 2016·Granted Aug 4, 2020·0 cites·2 claims
- 1051US2008118515A1Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of DiseasesPROTAGEN AG·Filed 2004·Application pending·0 cites
- 1148US2014093509A1Screening Method for the Identification of Agents Capable of Activating CD4+CD25+ Regulatory T-Cells Through Interactions with the HIV-1 GP120 Binding Site on CD4TCF GMBH·Filed 2013·Application pending·0 cites
- 1234US11447825B2In-vitro methods for the detection of autoimmune diseases or conditionsUNIV DER JOHANNES GUTENBERG UNIV MAINZ·Filed 2016·Granted Sep 20, 2022·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →